The platinum-based cancer drugs market is projected to rise from USD 1.88 billion in 2026 to USD 2.73 billion by 2034, expanding at a CAGR of 4.30% during 2026 to 2034, with North America the largest market in 2025. Innovation is a central theme. Newer formulations such as liposomal platinum compounds aim to improve drug delivery to cancer cells while minimizing damage to healthy tissue....